by | Sep 22, 2025 | Lupus Foundation of America, News & Events
AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus erythematosus met its primary endpoint. Trial results showed that subcutaneous administration of the therapy demonstrated a statistically...
by | Sep 19, 2025 | Lupus Foundation of America
The Lupus Foundation of America is proud to share its 2025 Impact Report, which highlights the progress we’ve made together to improve the lives of people affected by lupus.The stories and outcomes featured in the report show how we’re advancing our core strategic...
by | Sep 15, 2025 | Lupus Foundation of America
En Español This Hispanic Heritage Month, we celebrate the strength, resilience and leadership of the Hispanic/Latino community. Lupus has a profound impact on this community, and the Lupus Foundation of America’s work to provide support, education and resources...
by | Sep 15, 2025 | Lupus Foundation of America
En Español “Nuestra Voz, Nuestra Ciencia” — Our Voice, Our Science — is a powerful reminder that science, especially medical research, should reflect all voices. During Hispanic Heritage Month, we honor the strength, resilience and leadership of the Hispanic and...
by | Sep 15, 2025 | Lupus Foundation of America
Takeaways:For mutual support and hope, find 3 people to walk this journey with you- someone newly diagnosed, somebody that is in the same place you are and someone who has been living with lupus longer than you. As you age with lupus, think about your general health,...
by | Sep 12, 2025 | Lupus Foundation of America, News & Events
A new study has found a significant association between Epstein-Barr Virus (EBV), a highly contagious virus primarily spread through saliva, and systemic lupus erythematosus (SLE), highlighting a possible link in the virus’ role in SLE pathogenesis. People who are...
